Acute vision loss due to CML leukemic retinopathy reversed with leukapheresis. 2023

Sally Leong, and Tiffanie Do, and Michael Shodiya, and Jennifer Lee
Division of Hematology and Medical Oncology, Department of Medicine Harbor-UCLA Medical Center Torrance California USA.

Leukemic retinopathy is a severe complication of severe leukocytosis that results from untreated chronic myelogenous leukemia (CML). Immediate cytoreduction via leukapheresis may reverse ocular manifestations and prevent permanent vision damage. We present a case of a patient with acute unilateral vision loss found to have leukemic retinopathy in the setting of untreated CML with improvement of visual symptoms after leukapheresis and initiation of hydroxyurea.

UI MeSH Term Description Entries

Related Publications

Sally Leong, and Tiffanie Do, and Michael Shodiya, and Jennifer Lee
January 2023, Community eye health,
Sally Leong, and Tiffanie Do, and Michael Shodiya, and Jennifer Lee
March 1981, Lancet (London, England),
Sally Leong, and Tiffanie Do, and Michael Shodiya, and Jennifer Lee
December 2020, American journal of ophthalmology case reports,
Sally Leong, and Tiffanie Do, and Michael Shodiya, and Jennifer Lee
April 1993, Schweizerische medizinische Wochenschrift,
Sally Leong, and Tiffanie Do, and Michael Shodiya, and Jennifer Lee
June 1996, Deutsche medizinische Wochenschrift (1946),
Sally Leong, and Tiffanie Do, and Michael Shodiya, and Jennifer Lee
March 2019, Clinical & experimental ophthalmology,
Sally Leong, and Tiffanie Do, and Michael Shodiya, and Jennifer Lee
January 1997, Survey of ophthalmology,
Sally Leong, and Tiffanie Do, and Michael Shodiya, and Jennifer Lee
June 2021, Journal francais d'ophtalmologie,
Sally Leong, and Tiffanie Do, and Michael Shodiya, and Jennifer Lee
January 2014, Journal of pediatric ophthalmology and strabismus,
Sally Leong, and Tiffanie Do, and Michael Shodiya, and Jennifer Lee
December 2021, Ophthalmic genetics,
Copied contents to your clipboard!